“A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR”. Journal of Pharmaceutical Negative Results, Nov. 2022, pp. 217-25, https://doi.org/10.47750/pnr.2022.13.S09.026.